Advertisement
Australia markets open in 6 hours 48 minutes
  • ALL ORDS

    7,996.50
    -10.60 (-0.13%)
     
  • AUD/USD

    0.6522
    -0.0004 (-0.06%)
     
  • ASX 200

    7,735.80
    -9.80 (-0.13%)
     
  • OIL

    79.30
    -0.67 (-0.84%)
     
  • GOLD

    2,118.60
    +22.90 (+1.09%)
     
  • Bitcoin AUD

    102,178.84
    +6,780.97 (+7.11%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     

Vectus Biosystems Full Year 2023 Earnings: AU$0.072 loss per share (vs AU$0.12 loss in FY 2022)

Vectus Biosystems (ASX:VBS) Full Year 2023 Results

Key Financial Results

  • Revenue: AU$1.35m (up 4.2% from FY 2022).

  • Net loss: AU$3.45m (loss narrowed by 14% from FY 2022).

  • AU$0.072 loss per share (improved from AU$0.12 loss in FY 2022).

earnings-and-revenue-history
earnings-and-revenue-history

All figures shown in the chart above are for the trailing 12 month (TTM) period

Vectus Biosystems' share price is broadly unchanged from a week ago.

Risk Analysis

Be aware that Vectus Biosystems is showing 5 warning signs in our investment analysis and 3 of those are concerning...

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.